Clinical trials of a new, minimally invasive treatment for degenerated spinal discs have produced impressive results, significantly reducing back pain severity and improving function. It could mean ...

A new study sponsored by VIVEX Biologics, Inc. has shown promising results for patients suffering from chronic lumbar ...

VIVEX Biologics, Inc. sponsored research reports positive outcomes for patients with chronic lumbar discogenic pain treated ...

A single intradiscal injection of allogeneic NP reduced chronic lumbar discogenic pain and improved function at 12 months, ...

Mesenchymal precursor cells plus hyaluronic acid significantly reduced chronic low back pain due to degenerative disc disease.

Detailed price information for Biorestorative Therapies Inc (BRTX-Q) from The Globe and Mail including charting and trades.

BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator ...

BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on ...

Disability was measured using the Ostwestry Disability Index (ODI) and Neck Disability Index (NDI). Back/neck and arm/leg pain levels were also measured. Older surgeons also performed more ...